Aveir DR (pacemaker)

History

2025: Product Announcement

In mid-November 2025, Abbott announced the release of the Aveir DR device, the world's first dual-chamber electrodeless pacemaker. The solution is aimed at patients with delayed heart rhythm.

Aveir DR is implanted directly into the heart during a minimally invasive procedure using a catheter. Unlike traditional pacemakers, the device does not require electrodes and a pulse generator under the skin. This design reduces the likelihood of implantation-related complications. In addition, faster recovery of patients after surgery is achieved.

𝓲

Фото: worldrecordacademy.org

The Aveir DR system provides wireless communication between two electrodeless pacemakers. One stimulates the right ventricle (Aveir VR) and the other stimulates the right atrium (Aveir AR). Each such module is about ten times smaller than a traditional pacemaker - it is more compact than an AAA battery. The proprietary technology Abbott i2i (implant-implant) is implemented: it provides synchronized stimulation at each contraction of the heart in accordance with the clinical needs of the patient. The design provides for the possibility of extraction, which allows, if necessary, to replace the atrial or ventricular device.

The Aveir DR system is indicated in patients with sinus node weakness syndrome. With this pathology, the main driver of the heart rhythm cannot generate electrical impulses with the desired frequency and regularity, which leads to bradycardia (slow heart rate) and other rhythm disorders. In addition, a two-chamber electrodeless pacemaker can be used to treat chronic symptomatic grade 2 and 3 AV block: this is a serious heart rhythm disorder in which electrical impulses are poorly or not conducted at all from the atria to the ventricles.^[1]

Notes